{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:53:21Z","timestamp":1786136001055,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Clostridium difficile<\/jats:italic>\n                      infection (CDI) occurs in up to 30% of hematopoietic stem cell transplant (HSCT) recipients and remains a significant cause of infectious diarrhea. This meta-analysis evaluated the association of oral vancomycin prophylaxis (OVP) with CDI prevention after HSCT.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We conducted a literature search of PubMed, Cochrane, and Google Scholar for articles from inception to July 2025 that compared the safety and efficacy of OVP for CDI in post-HSCT patients. Statistical analysis of the extracted data was conducted using Review Manager 5.4. The odds ratio for dichotomous variables and the mean difference for continuous variables were analyzed along with the corresponding 95% confidence intervals. A random-effects model was applied when heterogeneity was high (\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2005\u2265\u200550%), and a fixed-effect model was applied when heterogeneity was low (\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2005\u2264\u200550%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      This meta-analysis included 5 studies comprising 957 patients, with 490 (51.2%) receiving OVP and 467 (48.8%) not receiving OVP (no OVP). OVP was significantly associated with a reduced incidence of CDI during hospitalization (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001). Although a lower overall incidence of CDI (hospitalization plus 180-day follow-up) was observed in the OVP group, the result was not statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.06). A leave-one-out analysis was performed to establish a significant association (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.04). In the OVP group, higher rates of grade 2 to 4 acute graft-versus-host disease (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.13) and lower rates of bloodstream infections (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.74), 1-year event-free survival (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.44), and longer hospital stays (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.36) were observed, although none reached statistical significance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>We conclude that oral vancomycin might be associated with a lower incidence of CDI during hospitalization in post-HSCT recipients and can be considered for CDI prophylaxis. No statistically significant adverse outcomes were observed in the OVP group compared with placebo. However, given the observational nature of these studies, these findings should be considered preliminary. Large-scale randomized controlled trials are needed to confirm the true efficacy and safety profile of OVP in post-HSCT recipients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050096","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T18:00:57Z","timestamp":1786125657000},"page":"e50096","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association of oral vancomycin prophylaxis with Clostridium difficile infection in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis"],"prefix":"10.1097","volume":"105","author":[{"given":"Maaz","family":"Amir","sequence":"first","affiliation":[{"name":"Department of Medicine, Mayo Hospital Lahore, King Edward Medical University, Lahore, Punjab, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khkula","family":"Kamal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Khyber Medical College, Peshawar, Khyber Pakhtunkhwa, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Asad","family":"Jahangir","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mayo Hospital Lahore, King Edward Medical University, Lahore, Punjab, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneeb","family":"Faiz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mayo Hospital Lahore, King Edward Medical University, Lahore, Punjab, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonaira","family":"Mushahid","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi, Sindh, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mujtaba","family":"Khokhar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shalamar Medical and Dental College, Lahore, Punjab, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Wasim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mayo Hospital Lahore, King Edward Medical University, Lahore, Punjab, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Sarmad","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mayo Hospital Lahore, King Edward Medical University, Lahore, Punjab, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asad Ullah","family":"Mehboob","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shalamar Medical and Dental College, Lahore, Punjab, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Moneeb","family":"Anwar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mayo Hospital Lahore, King Edward Medical University, Lahore, Punjab, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Maaz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shalamar Medical and Dental College, Lahore, Punjab, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Huzefa","family":"Amjad","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mayo Hospital Lahore, King Edward Medical University, Lahore, Punjab, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz Muhammad","family":"Haris","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mayo Hospital Lahore, King Edward Medical University, Lahore, Punjab, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9644-2272","authenticated-orcid":false,"given":"Muhammad Numan","family":"Awais","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shaheed Ziaur Rahman Medical College & Hospital, Bogura, Bangladesh."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mayo Hospital Lahore, King Edward Medical University, Lahore, Punjab, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260807","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/cid\/cir1035","article-title":"Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.","volume":"54","author":"Alonso","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R2-20260807","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(00)03592-3","article-title":"Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea.","volume":"357","author":"Kyne","year":"2001","journal-title":"Lancet"},{"key":"R3-20260807","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/cid\/ciaa124","article-title":"Antibiotic prescribing choices and their comparative C. difficile infection risks: a longitudinal case-cohort study.","volume":"72","author":"Brown","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R4-20260807","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.bbmt.2012.02.010","article-title":"Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.","volume":"18","author":"Willems","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"R8-20260807","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1017\/ice.2020.176","article-title":"Oral vancomycin prophylaxis against recurrent Clostridioides difficile infection: efficacy and side effects in two hospitals.","volume":"41","author":"Zacharioudakis","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R9-20260807","doi-asserted-by":"crossref","first-page":"e0124483","DOI":"10.1371\/journal.pone.0124483","article-title":"Prevalence of Clostridium difficile infection among solid organ transplant recipients: a meta-analysis of published studies.","volume":"10","author":"Paudel","year":"2015","journal-title":"PLoS One"},{"key":"R11-20260807","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/cid\/ciy822","article-title":"Oral vancomycin prophylaxis is highly effective in preventing Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients.","volume":"68","author":"Ganetsky","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R12-20260807","doi-asserted-by":"crossref","first-page":"e13790","DOI":"10.1111\/tid.13790","article-title":"Oral vancomycin for Clostridioides difficile prophylaxis in allogenic hematopoietic cell transplant.","volume":"24","author":"Altemeier","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"R13-20260807","doi-asserted-by":"crossref","first-page":"e70025","DOI":"10.1111\/tid.70025","article-title":"Prophylactic vancomycin in the primary prevention of Clostridium difficile in allogeneic stem cell transplant.","volume":"27","author":"Fusco","year":"2025","journal-title":"Transpl Infect Dis"},{"key":"R14-20260807","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1017\/ash.2024.90","article-title":"Effectiveness of oral vancomycin as prophylaxis against Clostridioides difficile infection in hematopoietic stem cell transplant patients.","volume":"4","author":"Reitmeyer","year":"2024","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"R15-20260807","doi-asserted-by":"crossref","first-page":"ofae622","DOI":"10.1093\/ofid\/ofae622","article-title":"Evaluation of primary oral vancomycin prophylaxis against Clostridioides difficile infection during autologous stem cell transplantation.","volume":"11","author":"Williams","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"R16-20260807","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials.","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"R17-20260807","doi-asserted-by":"crossref","first-page":"801475","DOI":"10.3389\/fcimb.2022.801475","article-title":"Prevalence of Clostridium difficile infection in the hematopoietic transplantation setting: update of systematic review and meta-analysis.","volume":"12","author":"Luo","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"R18-20260807","doi-asserted-by":"crossref","first-page":"E82","DOI":"10.1111\/j.1399-0012.2010.01331.x","article-title":"Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation.","volume":"25","author":"Chopra","year":"2011","journal-title":"Clin Transplant"},{"key":"R19-20260807","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/antibiotics11020183","article-title":"Oral vancomycin prophylaxis for primary and secondary prevention of Clostridioides difficile infection in patients treated with systemic antibiotic therapy: a systematic review, meta-analysis and trial sequential analysis.","volume":"11","author":"Maraolo","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"R20-20260807","doi-asserted-by":"crossref","first-page":"1756284821994046","DOI":"10.1177\/1756284821994046","article-title":"Efficacy of oral vancomycin prophylaxis for prevention of Clostridioides difficile infection: a systematic review and meta-analysis.","volume":"14","author":"Tariq","year":"2021","journal-title":"Ther Adv Gastroenterol"},{"key":"R21-20260807","article-title":"Impact of Clostridioides difficile infection on stem cell transplant outcomes \u2013 practical considerations for prevention and treatment [published online ahead of print October 2025].","author":"Lee","journal-title":"MRAJ"},{"key":"R22-20260807","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/cid\/ciaa395","article-title":"Metronidazole-associated neurologic events: a nested case-control study.","volume":"72","author":"Daneman","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R23-20260807","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/IPC.0000000000000375","article-title":"Initial therapy for mild to moderate Clostridium difficile infection.","volume":"24","author":"Siegfried","year":"2016","journal-title":"Infect Dis Clin Pract"},{"key":"R24-20260807","doi-asserted-by":"crossref","first-page":"a026989","DOI":"10.1101\/cshperspect.a026989","article-title":"Approved glycopeptide antibacterial drugs: mechanism of action and resistance.","volume":"6","author":"Zeng","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R25-20260807","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/antibiotics11020258","article-title":"Genetic mechanisms of vancomycin resistance in Clostridioides difficile: a systematic review.","volume":"11","author":"Eubank","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"R26-20260807","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fonc.2014.00089","article-title":"Possible implication of bacterial infection in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.","volume":"4","author":"Fuji","year":"2014","journal-title":"Front Oncol"},{"key":"R27-20260807","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.bbmt.2020.05.011","article-title":"The impact of antibiotic-mediated modification of the intestinal microbiome on outcomes of allogeneic hematopoietic cell transplantation: systematic review and meta-analysis.","volume":"26","author":"Gavriilaki","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"R28-20260807","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/bloodadvances.2020001984","article-title":"Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation.","volume":"4","author":"Zhang","year":"2020","journal-title":"Blood Adv"},{"key":"R29-20260807","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1017\/ice.2025.81","article-title":"Usage of oral vancomycin for acute Clostridioides difficile infection (CDI) resulting in later acquisitions of vancomycin-resistant enterococci (VRE).","volume":"46","author":"Rogozin","year":"2025","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R30-20260807","doi-asserted-by":"crossref","first-page":"e00936","DOI":"10.1128\/mSphere.00936-20","article-title":"Randomized controlled trial of oral vancomycin treatment in Clostridioides difficile-colonized patients.","volume":"6","author":"Fishbein","year":"2021","journal-title":"mSphere"},{"key":"R31-20260807","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/668422","article-title":"On the role of length of stay in healthcare-associated bloodstream infection.","volume":"33","author":"Jeon","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R32-20260807","doi-asserted-by":"crossref","first-page":"e70168","DOI":"10.1002\/hsr2.70168","article-title":"The extra length of stay, costs, and mortality associated with healthcare-associated infections: a case-control study.","volume":"7","author":"Moradi","year":"2024","journal-title":"Health Sci Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:01:43Z","timestamp":1786132903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":28,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050096","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"2025-09-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}